News
WHO Temporarily Suspends Use Of Chloroquine For Treatment Of COVID-19, Explains Why

The World Health Organization (WHO) on Monday, said it had “temporarily” suspended clinical trials of hydroxychloroquine, as potential treatment for COVID-19.
WHO Director-General, Tedros Adhanom Ghebreyesus, addressing a virtual press conference, said that the WHO-backed trials had been “suspended while the safety is reviewed”.
The decision has been taken, after a publication indicated that the use of Chloroquine could increase the likelihood of dying.
“It’s important to continue to gather evidence on the efficacy and safety of hydroxychloroquine.
“We want to use it if it’s safe and efficacious, reduces mortality, reduces the length of hospitalization without increasing adverse events,” WHO Chief Scientist, Soumya Swaminathan, added at the press briefing in Geneva.
-
Feature19 hours ago
US: Former DELSU Student Leaves BluePrint In Biomedical Sciences At Old Dominion University
-
Politics19 hours ago
2027: Sobotie, Keyamo, Nwoko, Others Meet President Tinubu
-
Opinion19 hours ago
Delta APC: A Handshake With The President, A House Still Divided
-
Column19 hours ago
More Concerns On Upgrading Osubi Airstrip Runway
-
Education13 hours ago
FUPRE Secures NUC Approval To Offer B.Sc. Programs In Logistics & Supply Chain Management, Procurement, Others